NFKB1 and lung disorder: We measured the expression of interleukin 8 (IL-8), representative of the chemokines induced by NF-κB and implicated in several pulmonary diseases; cyclooxygenase 2 (COX-2), characteristic of the enzymes induced by NF-κB and the molecular target of non-steroidal anti-inflammatory drugs; and the granulocyte-macrophage colony-stimulating factor (GM-CSF), representing the cytokines induced by NF-κB and associated with the GR’s histone acetylation mechanism of action.